Compare ALG & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | PTGX |
|---|---|---|
| Founded | 1955 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 5.4B |
| IPO Year | 1993 | 2016 |
| Metric | ALG | PTGX |
|---|---|---|
| Price | $173.12 | $85.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $225.00 | $90.56 |
| AVG Volume (30 Days) | 125.5K | ★ 1.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.64 | 0.72 |
| Revenue | ★ $1,615,388,000.00 | $209,217,000.00 |
| Revenue This Year | $1.26 | N/A |
| Revenue Next Year | $5.09 | $296.47 |
| P/E Ratio | ★ $17.88 | $119.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $156.30 | $33.70 |
| 52 Week High | $233.29 | $96.54 |
| Indicator | ALG | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 47.46 |
| Support Level | $161.99 | $88.30 |
| Resistance Level | $181.61 | $96.54 |
| Average True Range (ATR) | 4.79 | 3.46 |
| MACD | 1.88 | -0.61 |
| Stochastic Oscillator | 59.34 | 18.63 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.